Aarti Pharmalabs Ltd

543748


Key Metrics

Income Statement (in Bil, except ratios)
12/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
20.20 18.16 19.36 11.92
Revenue Growth %
10.82% -6.22% 62.41%
Gross Profit
8.24 7.01 5.31 3.12
Gross Profit Margin %
40.77% 38.59% 27.40% 26.20%
Operating Income
3.53 3.13 2.81 1.65
Operating Margin %
17.48% 17.23% 14.52% 13.86%
EBIT
3.64 3.15 2.79 1.56
EBIT Margin %
18.01% 17.33% 14.44% 13.06%
EBITDA
4.47 3.88 3.42 1.98
EBITDA Margin %
22.13% 21.37% 17.67% 16.60%
Net Income
2.49 2.17 1.93 1.22
Net Profit Margin %
12.34% 11.95% 9.99% 10.26%
Basic EPS
27.51 23.93 21.35 13.49
Diluted EPS
27.50 23.93 21.35 13.49
Normalized EPS
27.36 23.56 21.73
Total Dividends per Share
3.00 2.00
Balance Sheet (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
27,765.12 25,821.05 22,309.27 20,399.01 2.50
Total Liabilities
9,197.85 8,250.66 6,724.41 6,534.22 0.22
Total Debt
3,864.70 2,852.54 2,153.13 3,414.01 0.17
Total Equity
18,567.27 17,570.39 15,584.87 13,864.80 2.28
Cash And Cash Equivalents
408.08 236.35 249.30 832.73 2.50
Working Capital
6,931.86 6,512.52 5,641.94 4,474.84 2.28
Shares Outstanding (Bil)
90.63 90.63
90.63 90.63
Book Value Per Share
204.88 193.85 171.97
Total Debt To Equity
0.21 0.16 0.14 0.25 0.08
Cash Flow Statement (in Bil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
2.11 2.16 2.63 -0.44
Cash From Investing Activities
-2.92 -2.15 -1.58 -1.39
Cash From Financing Activities
1.10 0.10 -1.63 2.60
Capital Expenditures
2.99 1.99 1.20 1.41
Free Cash Flow
0.44 1.22 1.40 0.34
Change in Cash
0.29 0.12 -0.58 0.78

Profile

Name (Age)
5-Year Trend
2021
2022
2023
2024
2025
Hetal Gogri Gala (—) Vice Chairman of the Board and Managing Director
Narendra Jagannath Salvi (—) Director and Managing Director
Total Compensation for all Key Executives
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership


© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top